Literature DB >> 23408311

Infantile hemangiomas and retinopathy of prematurity: clues to the regulation of vasculogenesis.

Rachael M Hyland1, Katalin Komlósi, Brandon W Alleman, Marina Tolnai, Laura M Wood, Edward F Bell, Tibor Ertl.   

Abstract

UNLABELLED: Retinopathy of prematurity (ROP) and infantile hemangiomas are vascular disorders that may share common mechanisms. This study examined a potential clinical association between these disorders in populations of preterm infants at two hospitals in the USA and Hungary. Clinically collected data from infants with gestational ages less than 32 weeks born between May 1, 2007 and December 31, 2010 seen in the University of Iowa Children's Hospital or the Department of Obstetrics and Gynecology, University of Pécs, were abstracted from electronic medical records and entered into a study database. Demographic and clinical variables were examined as potential covariates to the disorders of interest. Data were initially analyzed by center and then combined through meta-analysis. Six hundred eighty-four subjects were studied: 236 from Pécs and 448 from Iowa. There were no significant demographic differences between populations. Univariate analysis on each study population yielded covariates to ROP in each population, including infantile hemangioma, which were entered into a logistic regression model. These models were combined through random-effects meta-analysis and demonstrated a significant relationship between infantile hemangioma and ROP (odds ratio = 1.84, 95 % confidence interval 1.08-3.12).
CONCLUSION: Infantile hemangioma and ROP co-occur in premature infant populations. Further studies are needed to investigate the pathogenesis of both disorders.

Entities:  

Mesh:

Year:  2013        PMID: 23408311      PMCID: PMC3664111          DOI: 10.1007/s00431-013-1966-y

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  40 in total

Review 1.  Infantile hemangioma-mechanism(s) of drug action on a vascular tumor.

Authors:  Shoshana Greenberger; Joyce Bischoff
Journal:  Cold Spring Harb Perspect Med       Date:  2011-09       Impact factor: 6.915

Review 2.  Visual development in preterm infants.

Authors:  Ashima Madan; James E Jan; William V Good
Journal:  Dev Med Child Neurol       Date:  2005-04       Impact factor: 5.449

Review 3.  The International Classification of Retinopathy of Prematurity revisited.

Authors: 
Journal:  Arch Ophthalmol       Date:  2005-07

4.  Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.

Authors:  Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde
Journal:  J Biomed Inform       Date:  2008-09-30       Impact factor: 6.317

5.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

6.  Role of the adrenergic system in a mouse model of oxygen-induced retinopathy: antiangiogenic effects of beta-adrenoreceptor blockade.

Authors:  Chiara Ristori; Luca Filippi; Massimo Dal Monte; Davide Martini; Maurizio Cammalleri; Pina Fortunato; Giancarlo la Marca; Patrizio Fiorini; Paola Bagnoli
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-01-05       Impact factor: 4.799

7.  Prospective study of infantile hemangiomas: demographic, prenatal, and perinatal characteristics.

Authors:  Anita N Haggstrom; Beth A Drolet; Eulalia Baselga; Sarah L Chamlin; Maria C Garzon; Kimberly A Horii; Anne W Lucky; Anthony J Mancini; Denise W Metry; Brandon Newell; Amy J Nopper; Ilona J Frieden
Journal:  J Pediatr       Date:  2007-03       Impact factor: 4.406

Review 8.  Infantile hemangioma: challenges, new insights, and therapeutic promise.

Authors:  Eileen Boye; Masatoshi Jinnin; Bjorn R Olsen
Journal:  J Craniofac Surg       Date:  2009-03       Impact factor: 1.046

9.  Rapamycin suppresses self-renewal and vasculogenic potential of stem cells isolated from infantile hemangioma.

Authors:  Shoshana Greenberger; Siming Yuan; Logan A Walsh; Elisa Boscolo; Kyu-Tae Kang; Benjamin Matthews; John B Mulliken; Joyce Bischoff
Journal:  J Invest Dermatol       Date:  2011-09-22       Impact factor: 8.551

10.  Suppressed NFAT-dependent VEGFR1 expression and constitutive VEGFR2 signaling in infantile hemangioma.

Authors:  Masatoshi Jinnin; Damian Medici; Lucy Park; Nisha Limaye; Yanqiu Liu; Elisa Boscolo; Joyce Bischoff; Miikka Vikkula; Eileen Boye; Bjorn R Olsen
Journal:  Nat Med       Date:  2008-10-19       Impact factor: 53.440

View more
  4 in total

Review 1.  Retinopathy of prematurity: contribution of inflammatory and genetic factors.

Authors:  Mariza Fevereiro-Martins; Hercília Guimarães; Carlos Marques-Neves; Manuel Bicho
Journal:  Mol Cell Biochem       Date:  2022-03-09       Impact factor: 3.396

2.  Association of Infantile Hemangiomas and Retinopathy of Prematurity: Analysis of the Multicenter KID.

Authors:  Nilesh Dankhara; Renjithkumar Kalikkot Thekkeveedu; Jaimin Patel; Jagdish Desai
Journal:  Biomed Hub       Date:  2022-01-31

Review 3.  Cardiovascular drugs in the treatment of infantile hemangioma.

Authors:  Israel Fernandez-Pineda; Regan Williams; Lucia Ortega-Laureano; Ryan Jones
Journal:  World J Cardiol       Date:  2016-01-26

4.  Ocular Versus Oral Propranolol for Prevention and/or Treatment of Oxygen-Induced Retinopathy in a Rat Model.

Authors:  Areej Qadri; Charles L Cai; Karen Deslouches; Faisal Siddiqui; Jacob V Aranda; Kay D Beharry
Journal:  J Ocul Pharmacol Ther       Date:  2021-02-03       Impact factor: 2.671

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.